Glucagon receptor antagonists, preparation and therapeutic uses

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 237/36 (2006.01) A61K 31/166 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2629348

The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.

La présente invention concerne de nouveaux composés de formule I, ou leurs sels pharmaceutiquement acceptables, qui possèdent une activité d'antagoniste ou d'agoniste inverse des récepteurs du glucagon, ainsi que des procédés de préparation de ces composés. Dans un autre mode de réalisation, l'invention concerne des compositions pharmaceutiques comprenant des composés de formule I, ainsi que des procédés les utilisant pour traiter des troubles diabétiques et d'autres troubles métaboliques liés au glucagon.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glucagon receptor antagonists, preparation and therapeutic uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucagon receptor antagonists, preparation and therapeutic uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon receptor antagonists, preparation and therapeutic uses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1993713

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.